Hope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, Debu Tripathy, Peter A Kaufman, Musa Mayer, Bongin Yoo, Oyewale O Abidoye, Denise A Yardley. Breast Cancer Res Treat 2013
Times Cited: 27
Times Cited: 27
Times Cited
Times Co-cited
Similarity
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
D J Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram,[...]. N Engl J Med 2001
D J Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram,[...]. N Engl J Med 2001
29
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
José Baselga, Javier Cortés, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg, Young-Hyuck Im, Laslo Roman, José Luiz Pedrini, Tadeusz Pienkowski, Adam Knott,[...]. N Engl J Med 2012
José Baselga, Javier Cortés, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg, Young-Hyuck Im, Laslo Roman, José Luiz Pedrini, Tadeusz Pienkowski, Adam Knott,[...]. N Engl J Med 2012
25
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.
Shaheenah Dawood, Kristine Broglio, Aman U Buzdar, Gabriel N Hortobagyi, Sharon H Giordano. J Clin Oncol 2010
Shaheenah Dawood, Kristine Broglio, Aman U Buzdar, Gabriel N Hortobagyi, Sharon H Giordano. J Clin Oncol 2010
22
Characteristics associated with differences in survival among black and white women with breast cancer.
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013
22
Disparities in breast cancer characteristics and outcomes by race/ethnicity.
Siew Loon Ooi, Maria Elena Martinez, Christopher I Li. Breast Cancer Res Treat 2011
Siew Loon Ooi, Maria Elena Martinez, Christopher I Li. Breast Cancer Res Treat 2011
18
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
18
Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.
Stephanie B Wheeler, Katherine E Reeder-Hayes, Lisa A Carey. Oncologist 2013
Stephanie B Wheeler, Katherine E Reeder-Hayes, Lisa A Carey. Oncologist 2013
18
Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Javaid Iqbal, Ophira Ginsburg, Paula A Rochon, Ping Sun, Steven A Narod. JAMA 2015
Javaid Iqbal, Ophira Ginsburg, Paula A Rochon, Ping Sun, Steven A Narod. JAMA 2015
18
Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population.
Kaitlin B Baron, Jennifer R Brown, Brian L Heiss, Joanne Marshall, Nancy Tait, Katherine H R Tkaczuk, Stephen S Gottlieb. J Card Fail 2014
Kaitlin B Baron, Jennifer R Brown, Brian L Heiss, Joanne Marshall, Nancy Tait, Katherine H R Tkaczuk, Stephen S Gottlieb. J Card Fail 2014
26
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study.
Peter A Kaufman, Adam M Brufsky, Musa Mayer, Hope S Rugo, Debu Tripathy, Marianne Ulcickas Yood, Shibao Feng, Lisa I Wang, Cheng S Quah, Denise A Yardley. Breast Cancer Res Treat 2012
Peter A Kaufman, Adam M Brufsky, Musa Mayer, Hope S Rugo, Debu Tripathy, Marianne Ulcickas Yood, Shibao Feng, Lisa I Wang, Cheng S Quah, Denise A Yardley. Breast Cancer Res Treat 2012
14
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015
14
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, Stacie C Jeter, Deborah Armstrong, Leisha A Emens, John Fetting, Antonio C Wolff,[...]. Cancer 2018
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, Stacie C Jeter, Deborah Armstrong, Leisha A Emens, John Fetting, Antonio C Wolff,[...]. Cancer 2018
17
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Martine J Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch,[...]. N Engl J Med 2005
Martine J Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch,[...]. N Engl J Med 2005
11
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Edward H Romond, Edith A Perez, John Bryant, Vera J Suman, Charles E Geyer, Nancy E Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A Kaufman,[...]. N Engl J Med 2005
Edward H Romond, Edith A Perez, John Bryant, Vera J Suman, Charles E Geyer, Nancy E Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A Kaufman,[...]. N Engl J Med 2005
11
Trastuzumab emtansine for HER2-positive advanced breast cancer.
Sunil Verma, David Miles, Luca Gianni, Ian E Krop, Manfred Welslau, José Baselga, Mark Pegram, Do-Youn Oh, Véronique Diéras, Ellie Guardino,[...]. N Engl J Med 2012
Sunil Verma, David Miles, Luca Gianni, Ian E Krop, Manfred Welslau, José Baselga, Mark Pegram, Do-Youn Oh, Véronique Diéras, Ellie Guardino,[...]. N Engl J Med 2012
11
Adjuvant trastuzumab in HER2-positive breast cancer.
Dennis Slamon, Wolfgang Eiermann, Nicholas Robert, Tadeusz Pienkowski, Miguel Martin, Michael Press, John Mackey, John Glaspy, Arlene Chan, Marek Pawlicki,[...]. N Engl J Med 2011
Dennis Slamon, Wolfgang Eiermann, Nicholas Robert, Tadeusz Pienkowski, Miguel Martin, Michael Press, John Mackey, John Glaspy, Arlene Chan, Marek Pawlicki,[...]. N Engl J Med 2011
11
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Charles E Geyer, John Forster, Deborah Lindquist, Stephen Chan, C Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman,[...]. N Engl J Med 2006
Charles E Geyer, John Forster, Deborah Lindquist, Stephen Chan, C Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman,[...]. N Engl J Med 2006
11
Prognostic factors in 1,038 women with metastatic breast cancer.
R Largillier, J-M Ferrero, J Doyen, J Barriere, M Namer, V Mari, A Courdi, J M Hannoun-Levi, F Ettore, I Birtwisle-Peyrottes,[...]. Ann Oncol 2008
R Largillier, J-M Ferrero, J Doyen, J Barriere, M Namer, V Mari, A Courdi, J M Hannoun-Levi, F Ettore, I Birtwisle-Peyrottes,[...]. Ann Oncol 2008
11
Survival differences among women with de novo stage IV and relapsed breast cancer.
S Dawood, K Broglio, J Ensor, G N Hortobagyi, S H Giordano. Ann Oncol 2010
S Dawood, K Broglio, J Ensor, G N Hortobagyi, S H Giordano. Ann Oncol 2010
11
Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.
Shaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, Aman U Buzdar, Gabriel N Hortobagyi, Sharon H Giordano. J Clin Oncol 2008
Shaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, Aman U Buzdar, Gabriel N Hortobagyi, Sharon H Giordano. J Clin Oncol 2008
11
Fifteen-year trends in metastatic breast cancer survival in Greece.
U Dafni, I Grimani, A Xyrafas, A G Eleftheraki, G Fountzilas. Breast Cancer Res Treat 2010
U Dafni, I Grimani, A Xyrafas, A G Eleftheraki, G Fountzilas. Breast Cancer Res Treat 2010
11
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
Blase N Polite, Constance Cirrincione, Gini F Fleming, Donald A Berry, Andrew Seidman, Hyman Muss, Larry Norton, Charles Shapiro, Kamal Bakri, Kelly Marcom,[...]. J Clin Oncol 2008
Blase N Polite, Constance Cirrincione, Gini F Fleming, Donald A Berry, Andrew Seidman, Hyman Muss, Larry Norton, Charles Shapiro, Kamal Bakri, Kelly Marcom,[...]. J Clin Oncol 2008
12
Trastuzumab containing regimens for early breast cancer.
Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri, Roberto D'Amico. Cochrane Database Syst Rev 2012
Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri, Roberto D'Amico. Cochrane Database Syst Rev 2012
11
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.
Charles L Vogel, Melody A Cobleigh, Debu Tripathy, John C Gutheil, Lyndsay N Harris, Louis Fehrenbacher, Dennis J Slamon, Maureen Murphy, William F Novotny, Michael Burchmore,[...]. J Clin Oncol 2002
Charles L Vogel, Melody A Cobleigh, Debu Tripathy, John C Gutheil, Lyndsay N Harris, Louis Fehrenbacher, Dennis J Slamon, Maureen Murphy, William F Novotny, Michael Burchmore,[...]. J Clin Oncol 2002
11
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Thomas M Suter, Marion Procter, Dirk J van Veldhuisen, Michael Muscholl, Jonas Bergh, Chiara Carlomagno, Timothy Perren, Rodolfo Passalacqua, Claudia Bighin, Jan G M Klijn,[...]. J Clin Oncol 2007
Thomas M Suter, Marion Procter, Dirk J van Veldhuisen, Michael Muscholl, Jonas Bergh, Chiara Carlomagno, Timothy Perren, Rodolfo Passalacqua, Claudia Bighin, Jan G M Klijn,[...]. J Clin Oncol 2007
11
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Edith A Perez, Vera J Suman, Nancy E Davidson, George W Sledge, Peter A Kaufman, Clifford A Hudis, Silvana Martino, Julie R Gralow, Shaker R Dakhil, James N Ingle,[...]. J Clin Oncol 2008
Edith A Perez, Vera J Suman, Nancy E Davidson, George W Sledge, Peter A Kaufman, Clifford A Hudis, Silvana Martino, Julie R Gralow, Shaker R Dakhil, James N Ingle,[...]. J Clin Oncol 2008
11
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
Erin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, Adedayo A Onitilo, Andrew N Freedman, Thomas Delate, Larry A Allen, Larissa Nekhlyudov, Katrina A B Goddard, Robert L Davis,[...]. J Natl Cancer Inst 2012
Erin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, Adedayo A Onitilo, Andrew N Freedman, Thomas Delate, Larry A Allen, Larissa Nekhlyudov, Katrina A B Goddard, Robert L Davis,[...]. J Natl Cancer Inst 2012
11
11
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors.
David N Danforth. Breast Cancer Res 2013
David N Danforth. Breast Cancer Res 2013
11
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
Carol E DeSantis, Stacey A Fedewa, Ann Goding Sauer, Joan L Kramer, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2016
Carol E DeSantis, Stacey A Fedewa, Ann Goding Sauer, Joan L Kramer, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2016
11
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.
Ayal A Aizer, Tyler J Wilhite, Ming-Hui Chen, Powell L Graham, Toni K Choueiri, Karen E Hoffman, Neil E Martin, Quoc-Dien Trinh, Jim C Hu, Paul L Nguyen. Cancer 2014
Ayal A Aizer, Tyler J Wilhite, Ming-Hui Chen, Powell L Graham, Toni K Choueiri, Karen E Hoffman, Neil E Martin, Quoc-Dien Trinh, Jim C Hu, Paul L Nguyen. Cancer 2014
11
Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Tomi Akinyemiju, Justin Xavier Moore, Akinyemi I Ojesina, John W Waterbor, Sean F Altekruse. Breast Cancer Res Treat 2016
Tomi Akinyemiju, Justin Xavier Moore, Akinyemi I Ojesina, John W Waterbor, Sean F Altekruse. Breast Cancer Res Treat 2016
11
Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.
Carol E DeSantis, Rebecca L Siegel, Ann Goding Sauer, Kimberly D Miller, Stacey A Fedewa, Kassandra I Alcaraz, Ahmedin Jemal. CA Cancer J Clin 2016
Carol E DeSantis, Rebecca L Siegel, Ann Goding Sauer, Kimberly D Miller, Stacey A Fedewa, Kassandra I Alcaraz, Ahmedin Jemal. CA Cancer J Clin 2016
11
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
11
Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
Dawn L Hershman, Joseph M Unger, William E Barlow, Laura F Hutchins, Silvana Martino, C Kent Osborne, Robert B Livingston, Kathy S Albain. J Clin Oncol 2009
Dawn L Hershman, Joseph M Unger, William E Barlow, Laura F Hutchins, Silvana Martino, C Kent Osborne, Robert B Livingston, Kathy S Albain. J Clin Oncol 2009
11
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.
Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, Pavel Hoffmann, Jeanette Schulz-Menger, Morten W Fagerland, Berit Gravdehaug, Florian von Knobelsdorff-Brenkenhoff, Åse Bratland, Tryggve H Storås,[...]. Eur Heart J 2016
Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, Pavel Hoffmann, Jeanette Schulz-Menger, Morten W Fagerland, Berit Gravdehaug, Florian von Knobelsdorff-Brenkenhoff, Åse Bratland, Tryggve H Storås,[...]. Eur Heart J 2016
11
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
Edward H Romond, Jong-Hyeon Jeong, Priya Rastogi, Sandra M Swain, Charles E Geyer, Michael S Ewer, Vikas Rathi, Louis Fehrenbacher, Adam Brufsky, Catherine A Azar,[...]. J Clin Oncol 2012
Edward H Romond, Jong-Hyeon Jeong, Priya Rastogi, Sandra M Swain, Charles E Geyer, Michael S Ewer, Vikas Rathi, Louis Fehrenbacher, Adam Brufsky, Catherine A Azar,[...]. J Clin Oncol 2012
11
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015
Li Tao, Scarlett Lin Gomez, Theresa H M Keegan, Allison W Kurian, Christina A Clarke. Cancer Epidemiol Biomarkers Prev 2015
11
Racial disparities in treatment and survival among women with early-stage breast cancer.
Dawn Hershman, Russell McBride, Judith S Jacobson, Lois Lamerato, Kevin Roberts, Victor R Grann, Alfred I Neugut. J Clin Oncol 2005
Dawn Hershman, Russell McBride, Judith S Jacobson, Lois Lamerato, Kevin Roberts, Victor R Grann, Alfred I Neugut. J Clin Oncol 2005
11
Comorbidity and survival disparities among black and white patients with breast cancer.
C Martin Tammemagi, David Nerenz, Christine Neslund-Dudas, Carolyn Feldkamp, David Nathanson. JAMA 2005
C Martin Tammemagi, David Nerenz, Christine Neslund-Dudas, Carolyn Feldkamp, David Nathanson. JAMA 2005
11
Metastatic behavior of breast cancer subtypes.
Hagen Kennecke, Rinat Yerushalmi, Ryan Woods, Maggie Chon U Cheang, David Voduc, Caroline H Speers, Torsten O Nielsen, Karen Gelmon. J Clin Oncol 2010
Hagen Kennecke, Rinat Yerushalmi, Ryan Woods, Maggie Chon U Cheang, David Voduc, Caroline H Speers, Torsten O Nielsen, Karen Gelmon. J Clin Oncol 2010
7
Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.
Adedayo A Onitilo, Jessica M Engel, Robert T Greenlee, Bickol N Mukesh. Clin Med Res 2009
Adedayo A Onitilo, Jessica M Engel, Robert T Greenlee, Bickol N Mukesh. Clin Med Res 2009
7
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era.
Erin M Olson, Julie S Najita, Jessica Sohl, Amal Arnaout, Harold J Burstein, Eric P Winer, Nancy U Lin. Breast 2013
Erin M Olson, Julie S Najita, Jessica Sohl, Amal Arnaout, Harold J Burstein, Eric P Winer, Nancy U Lin. Breast 2013
7
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
7
Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003.
Xianglin L Du, Charles C Lin, Norman J Johnson, Sean Altekruse. Cancer 2011
Xianglin L Du, Charles C Lin, Norman J Johnson, Sean Altekruse. Cancer 2011
7
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Joseph A Sparano, Molin Wang, Fengmin Zhao, Vered Stearns, Silvana Martino, Jennifer A Ligibel, Edith A Perez, Tom Saphner, Antonio C Wolff, George W Sledge,[...]. J Natl Cancer Inst 2012
Joseph A Sparano, Molin Wang, Fengmin Zhao, Vered Stearns, Silvana Martino, Jennifer A Ligibel, Edith A Perez, Tom Saphner, Antonio C Wolff, George W Sledge,[...]. J Natl Cancer Inst 2012
7
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.
M A Cobleigh, C L Vogel, D Tripathy, N J Robert, S Scholl, L Fehrenbacher, J M Wolter, V Paton, S Shak, G Lieberman,[...]. J Clin Oncol 1999
M A Cobleigh, C L Vogel, D Tripathy, N J Robert, S Scholl, L Fehrenbacher, J M Wolter, V Paton, S Shak, G Lieberman,[...]. J Clin Oncol 1999
7
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
Sara M Tolaney, William T Barry, Chau T Dang, Denise A Yardley, Beverly Moy, P Kelly Marcom, Kathy S Albain, Hope S Rugo, Matthew Ellis, Iuliana Shapira,[...]. N Engl J Med 2015
Sara M Tolaney, William T Barry, Chau T Dang, Denise A Yardley, Beverly Moy, P Kelly Marcom, Kathy S Albain, Hope S Rugo, Matthew Ellis, Iuliana Shapira,[...]. N Engl J Med 2015
7
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.
Sharon H Giordano, Sarah Temin, Jeffrey J Kirshner, Sarat Chandarlapaty, Jennie R Crews, Nancy E Davidson, Francisco J Esteva, Ana M Gonzalez-Angulo, Ian Krop, Jennifer Levinson,[...]. J Clin Oncol 2014
Sharon H Giordano, Sarah Temin, Jeffrey J Kirshner, Sarat Chandarlapaty, Jennie R Crews, Nancy E Davidson, Francisco J Esteva, Ana M Gonzalez-Angulo, Ian Krop, Jennifer Levinson,[...]. J Clin Oncol 2014
7
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.